Eukaryotic translation initiation factor 1 pseudogene 2 (EIF1P2)

EIF1P2 is annotated as a "pseudogene" of the eukaryotic translation initiation factor 1 (EIF1) family. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional due to mutations, truncations, or lack of regulatory elements required for expression. The canonical eukaryotic translation initiation factor 1 (EIF1) is a protein component required for accurate scanning and recognition of the translation start site on mRNA during protein synthesis initiation in eukaryotes. EIF1 itself is crucial in cell growth and stress response mechanisms, but EIF1P2 does not produce a functional protein and is not classified as a therapeutic target, nor is it involved in molecular interactions, disease mechanisms, or known to act as a biomarker or drug safety concern. EIF1P2 is not an active gene but a non-coding pseudogene—there is no evidence it encodes a protein. It is not a receptor, enzyme, transporter, transcription factor, nor does it fall into any classical target category. There are no known biological functions, disease associations, molecular interactions, therapeutic agents, or biomarkers related to EIF1P2. The correct "therapeutic target" would be EIF1 (eukaryotic translation initiation factor 1), not EIF1P2. EIF1P2 should not be considered a genuine molecular target. It is a misannotation or reference to a non-functional pseudogene, rather than a protein, enzyme, or receptor relevant for drug discovery or biological mechanism studies. If the intent was to refer to a translation initiation factor, the correct reference should be to the functional gene/protein "eukaryotic translation initiation factor 1 (EIF1)" rather than the pseudogene.

Other names

EIF1 pseudogene 2eukaryotic translation initiation factor 1 pseudogene 2